Neurofilament-immunoreactive neurons in Alzheimer's disease and dementia with Lewy bodies

Neurobiology of Disease

Volumn 9, Issue 2, 2002, Pages 249-257

  Shepherd, Claire E ^a,b   McCann, Heather ^a   Thiel, Emma ^a   Halliday, Glenda M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; FORMALDEHYDE;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CELL; CELL COUNT; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; LEWY BODY; MALE; NEUROFILAMENT; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TEMPORAL CORTEX;

EID: 0036194258     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2001.0469     Document Type: Article

References (45)

1. Neuropathological staging of Alzheimer-related changes
2. Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease
3. Relationship between DNA fragmentation, morphological changes and neuronal loss in Alzheimer's disease and dementia with Lewy bodies
4. Phosphorylated neurofilament antigens in neurofibrillary tangles in Alzheimer's disease
5. Protective effect of neurofilament heavy gene over-expression in motor neuron disease induced by mutant superoxide dismutase
6. Extra axonal neurofilaments do not exacerbate disease caused by mutant Cu, Zn superoxide dismutase
7. Cell loss in the nucleus basalis is related to regional cortical atrophy in Alzheimer's disease
8. Topography of brain atrophy during normal aging and Alzheimer's disease
9. Immunoreactivity patterns in neurofibrillary tangles of the inferior temporal cortex in Alzheimer's disease
10. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha, beta and gamma synuclein
11. Clinicopathological correlates in temporal cortex in dementia with Lewy bodies
12. Cortical neurons expressing calcium binding proteins are spared in dementia with Lewy bodies
13. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis
14. Specific temporoparietal gyral atrophy reflects the pattern of language dissolution in Alzheimer's disease
15. Simplified neuropathological diagnosis of dementia with Lewy bodies
16. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex
17. Attenuated neurodegenerative disease phenotype in tau transgenic mouse lacking neurofilaments
18. Age-dependent emergence and progression of a tauopathy in transgenic mice over-expressing the shortest human tau isoform
19. Neuronal response to physical injury and its relationship to the pathology of Alzheimer's disease
20. Perikaryal neurofilament phosphorylation in axotomised and 6-OH-dopamine-lesioned CNS neurons
21. Over-expression of neurofilament subunit NF-L and NF-H extends survival of a mouse model for amylotrophic lateral sclerosis
22. Neuron loss from the hippocampus of Alzheimer's disease exceeds extracellular neurofibrillary tangle formation
23. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein
24. Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease
25. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: Implications for neurodegenerative disorders
26. An antibody against phosphorylated neurofilaments identifies a subset of damaged association axons in Alzheimer's disease
27. Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter
28. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
29. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardisation of the neuropathologic assessment of Alzheimer's disease
30. Neurons may live for decades with neurofibrillary tangles
31. A monoclonal antibody to non-phosphorylated neurofilament protein marks the vulnerable cortical neurons in Alzheimer's disease
32. Biochemical and anatonical redistribution of tau protein in Alzheimer's disease
33. Pathology and biology of the Lewy body
34. Neurofilament-immunoreactive neurons are not selectively vulnerable in Alzheimer's disease
35. Both total and phosphorylated tau are increased in Alzheimer's disease
36. Fragmentation of the neuronal cytoskeleton in the Lewy body variant of Alzheimer's disease
37. Cell death or synaptic loss in Alzheimer's disease
38. Reductions in motoneuronal neurofilament synthesis by successive axotomies: A possible explanation for the conditioned lesioning effect on axon regeneration
39. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease
40. Aggregation of neurofilament and alpha synuclein proteins in Lewy bodies
41. Selective degeneration of purkinje cells with Lewy body-like inclusions in aged NFHLacZ transgenic mice
42. Neuropathology in mice expressing human alpha-synuclein
43. Cortical Lewy body-containing neurons are pyramidal ceils: Laser confocal imaging of double-immunolabeled sections with anti-ubiquitin and SMI32
44. Differential regulation of peripherin and neurofilament gene expression in regenerating rat DRG neurons